As of November 1, 2018, the pharmaceutical protein production facility in the Netherlands acquired by WACKER with its takeover of SynCo Bio Partners Luxembourg S.à r.l., will be renamed Wacker Biotech B.V.
Thanks to the strong performance of its chemical business, Wacker Chemie AG’s sales and EBITDA continued to grow in the second quarter of 2018, both year over year and quarter over quarter.
WACKER BIOSOLUTIONS, the life sciences division of the WACKER Group, has begun producing fermentation-generated cystine at its new site in León, Spain.
WACKER POLYMERS is raising its prices for vinyl-acetate-ethylene-based copolymer dispersions, dispersible polymer powders and solid resins of its VINNAPAS®, VINNOL®, ETONIS®, VINNACEL® and SMARGO® brands worldwide.